SCHEMBL7511993

SCHEMBL7511993

O=C(O)CC(=O)CCc1cccc(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
KMT2A Q03164 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.57
PLAAT3 P53816 2/20 0.57
PLAAT5 Q96KN8 2/20 0.57
PLAAT2 Q9NWW9 2/20 0.57
PLAAT4 Q9UL19 2/20 0.57
MMP12 P39900 1/20 0.54
MEN1 O00255 1/20 0.54
HPGD P15428 1/20 0.54
TAAR1 Q96RJ0 3/20 0.51
THRA P10827 1/20 0.51
THRB P10828 1/20 0.51
FFAR1 O14842 1/20 0.51
FFAR4 Q5NUL3 1/20 0.51
CNR1 P21554 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
CTBP2 P56545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7332799 0.88 TAAR1 (0.57) ALDH1A1KMT2ASMN1; SMN2PLAAT3PLAAT5
SCHEMBL20897236 0.87 PLAAT3 (0.58) ALDH1A1KMT2ASMN1; SMN2PLAAT3PLAAT5
SCHEMBL80581 0.86 ALDH1A1 (0.67) ALDH1A1KMT2ASMN1; SMN2PLAAT3PLAAT5
SCHEMBL27834585 0.83 CTBP2 (0.58) ALDH1A1KMT2ASMN1; SMN2MEN1HPGD
SCHEMBL11064961 0.81 PLAAT3 (0.52) ALDH1A1KMT2ASMN1; SMN2PLAAT3PLAAT5
SCHEMBL7507667 0.80 MMP12 (0.54) ALDH1A1KMT2AMMP12MEN1TAAR1
SCHEMBL13561129 0.80 PLAAT3 (0.57) ALDH1A1KMT2ASMN1; SMN2PLAAT3PLAAT5
SCHEMBL28210558 0.80 FFAR1 (0.57) ALDH1A1KMT2AMMP12MEN1TAAR1
SCHEMBL7507038 0.80 MMP12 (0.54) ALDH1A1MMP12HPGDFFAR1
SCHEMBL28874674 0.80 PLAAT3 (0.50) ALDH1A1KMT2ASMN1; SMN2PLAAT3PLAAT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083827-A Thiazolidine compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD 2011-06-01 CN disclosed
EP-1042320-B1 NEW COMPOUNDS WHICH ARE P2-PURINOCEPTOR 7-TRANSMEMBRANE (TM) G-PROTEIN COUPLED RECEPTOR ANTAGONISTS ASTRAZENECA UK LTD (GB) 2002-02-13 EP disclosed
US-6218376-B1 FOR TREATING INFLAMMATORY DISEASES ASTRAZENECA UK LIMITED (GB) 2001-04-17 US disclosed
EP-1042320-A1 NEW COMPOUNDS WHICH ARE P2-PURINOCEPTOR 7-TRANSMEMBRANE (TM) G-PROTEIN COUPLED RECEPTOR ANTAGONISTS AstraZeneca UK Limited (GB) 2000-10-11 EP disclosed
WO-1999026944-A1 NEW COMPOUNDS WHICH ARE P2-PURINOCEPTOR 7-TRANSMEMBRANE (TM) G-PROTEIN COUPLED RECEPTOR ANTAGONISTS ASTRAZENEKA UK LIMITED (GB) 1999-06-03 WO disclosed
EP-0068460-A1 Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO. INC. (US) 1983-01-05 EP disclosed